AMYLOID SOLUTION
Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments. The company focuses on pathophysiological events related to disease progression and its underlying mechanism to find novel therapeutics, enabling clients with the best solution for Alzheimer disease.
AMYLOID SOLUTION
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Status:
Active
Contact:
+82-31-8092-3800
Total Funding:
27.44 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apache Mobile Non Scaleable Content ReCAPTCHA Cloudflare JS CDN JS AJAX Libraries API JQuery CDN
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Biopalette
Biopalette is a operator of a platform intended to offer gene-editing techniques.
Current Employees Featured
YoungSoo Kim Co-Founder & Chief Scientific Officer @ Amyloid Solution
Co-Founder & Chief Scientific Officer
2017-09-01
Jintae Chang Chief Executive Officer @ Amyloid Solution
Chief Executive Officer
2017-09-01
Founder
Investors List
Kclavis
Kclavis investment in Series B - Amyloid Solution
Korea Development Bank
Korea Development Bank investment in Series B - Amyloid Solution
Yuhan Corporation
Yuhan Corporation investment in Series B - Amyloid Solution
TS Investment
TS Investment investment in Series B - Amyloid Solution
WONIK Investment Partners
WONIK Investment Partners investment in Series A - Amyloid Solution
StarTec Investments
StarTec Investments investment in Series A - Amyloid Solution
TS Investment
TS Investment investment in Series A - Amyloid Solution
KTB Network
KTB Network investment in Series A - Amyloid Solution
Innopolis Partners
Innopolis Partners investment in Series A - Amyloid Solution
Saehan Startup Investment
Saehan Startup Investment investment in Series A - Amyloid Solution
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-11-02 | Deargen | Amyloid Solution investment in Seed Round - Deargen | 3 B KRW |
More informations about "Amyloid Solution"
Amyloid Solution - Crunchbase Investor Profile & Investments
Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments. The company focuses on pathophysiological events related to disease …See details»
AMYLOID SOLUTION
“Erasing Alzheimer's Disease” is the mission of Amyloid Solution and the reason we exist. To erase the disorder, our R&D focuses on everything of Alzheimer’s disease. We search for …See details»
Amyloid Solution Inc. - LinkedIn
Amyloid Solution Inc. | 325 followers on LinkedIn. “Erasing Alzheimer's Disease” | “Erasing Alzheimer's Disease” is the mission of Amyloid Solution and the reason we exist. To erase the ...See details»
Amyloid Solution - Products, Competitors, Financials, Employees ...
About Amyloid Solution Amyloid Solution focuses on developing disease-modifying treatments for Alzheimer's disease within the biopharmaceutical industry. The company's main offerings …See details»
What Has ‘Amyloid Solution’ Been Solving for Alzheimer’s?
Nov 29, 2021 Amyloid Solution, headquartered in Seongnam, South Korea, is a biotechnology company with a mission “Erasing Alzheimer's Disease”, focusing on everything about AD to …See details»
Amyloid Solution - Funding, Financials, Valuation & Investors
Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments.See details»
Amyloid Solution - VentureRadar
"Amyloid Solution is developing innovative disease-modifying treatments for patients of Alzheimer's disease in different stages with diverse pathological alterations."See details»
Amyloid Solution - Investments, Portfolio & Company Exits
Oct 26, 2020 Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments.See details»
Amyloid Solution - teaserclub.com
Amyloid Solution Inc., based in Seongnam, South Korea, specializes in developing drug therapies aimed at treating Alzheimer's disease. The company focuses on understanding the …See details»
Amyloid Solution Inc. - BIO Investor Forum 2024
Oct 16, 2024 Amyloid Solution Inc. is a pioneering biotech company at the forefront of discovering disease-modifying targets and developing novel drug candidates, including small …See details»
Amyloid Solution raises $14.8M Series B...Yuhan participates as ...
Apr 16, 2020 Jang Jin-tae, CEO of Amyloid Solution, said “This investment has enabled us to build a new clinical organization and secure global execution capabilities. Despite the …See details»
Small study hints anti-amyloid therapy may keep Alzheimer’s
Mar 19, 2025 For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from the brains of people destined to develop Alzheimer’s …See details»
AmyGo Solutions | Amyloidosis
AmyGo Solutions is a new biotech company focused on developing diagnostics and therapeutics for systemic amyloidosis. This disease is characterized by the misfolding and accumulation of …See details»
AS-603 - Drug Targets, Indications, Patents - Synapse
6 days ago AS-603: a APP inhibitors, TAU inhibitors Drug, Initially developed by Amyloid Solution Co., Ltd., Now, its global highest R&D status is Preclinical, Mechanism: APP …See details»
Amyloidosis Canada – The Canadian Amyloidosis Support Network
What is CASN? The Canadian Amyloidosis Support Network, Inc., is a federally registered, not-for-profit, all-volunteer organization formed by amyloidosis patients and those close to them. …See details»
Dual modulation of amyloid beta and tau aggregation and …
2 days ago Alzheimer’s disease (AD) is not a single-cause disease; rather, it is a complex neurodegenerative disease involving multiple pathological pathways influenced by various risk …See details»
Home | Amyloidosis Foundation
By submitting this form, you are consenting to receive marketing emails from : Amyloidosis Foundation, 7151 N. Main St., Suite 2, Clarkston, MI, 48346, US, https://www.amyloidosis.org. …See details»
Emerging biophysical origins and pathogenic implications of …
2 days ago For decades, research on Alzheimer’s disease and dementia has lacked a unified framework. This Perspective explores the convergence of key amyloid protein oligomerization …See details»
Amyloid is everywhere, but new treatments could stop the toxic
Nov 11, 2024 Amyloid deposits are present in the brains of cognitively impaired individuals, but also accumulate throughout the body. Some biotechs aim to keep these misfolded proteins in …See details»
The Search for an Amyloid Solution | Science
Nov 1, 2002 The amyloid hypothesis has guided research on Alzheimer's disease (AD) for the past decade. The central tenet of the hypothesis has been that aggregation of fibrillar amyloid …See details»